Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 30.06.2025 1 Am J Kidney Dis 1 Ann Neurol 2 Curr Opin Immunol 4 Diabetes 1 Intern Med 2 J Autoimmun 4 J Neuroimmunol 1 J Neurol 1 J Pediatr 2 Kidney Int 2 Lancet Neurol 1 Mult Scler 1 Neurologia (Engl Ed) 5 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. CHUNG EY, Carter SA, Jaure A, Howell M, et al
   Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview Study.
   Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. SACCO S, Papinutto N, Schoeps VA, Cheng S, et al
   High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis.
   Ann Neurol. 2025 Jun 24. doi: 10.1002/ana.27298.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

3. NIE W, Yang X, Ma M, Xu X, et al
   Chimeric antigen receptor T cell therapy for autoimmune diseases.
   Curr Opin Immunol. 2025;95:102596.
   PubMed         Abstract available
   
   
4. DAI M, Mei B, Zheng F, Ballestar E, et al
   Sex hormones and epigenetic dysregulation in autoimmune disease.
   Curr Opin Immunol. 2025;95:102595.
   PubMed         Abstract available
   
   

   
   Diabetes

5. HERING BJ, Rickels MR, Bellin MD, Millman JR, et al
   Advances in Cell Replacement Therapies for Diabetes.
   Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
   PubMed         Abstract available
   
   
6. PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al
   Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
   Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
   PubMed         Abstract available
   
   
7. JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al
   The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.
   Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
   PubMed         Abstract available
   
   
8. BILAL A, Casu A, Yi F, Dutta T, et al
   A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
   Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096.
   PubMed         Abstract available
   
   

   
   Intern Med

9. OHNISHI M, Anno T, Takahashi K, Okauchi S, et al
   Continuously High Titers of Multiple Islet-associated Autoantibodies in an Individual with an Elderly Onset of Type 1 Diabetes Mellitus and Basedow's Disease: A Case Report with a Review of Literature.
   Intern Med. 2025 Jun 26. doi: 10.2169/internalmedicine.5567.
   PubMed         Abstract available
   
   

   
   J Autoimmun

10. VAN DEN BEUKEL MD, Zhang L, van der Meulen S, Borggreven NV, et al
    Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.
    J Autoimmun. 2025;155:103444.
    PubMed         Abstract available
    
    
11. LEE YJ, Fang YW, Chen MT, Liou HH, et al
    Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study.
    J Autoimmun. 2025;155:103453.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

12. NASEER MA, Hegazy M, El-Mehdawy KM, Ashraf H, et al
    Serum levels of tumor necrosis factor and TNFRSF1A gene polymorphisms in Egyptian multiple sclerosis patients: the influence on susceptibility and severity.
    J Neuroimmunol. 2025;406:578672.
    PubMed         Abstract available
    
    
13. PEREIRA DA, Mariano M, Marcon N, Maia MM, et al
    A rare neuroendocrine presentation in pediatric anti-glutamic acid decarboxylase autoimmunity: Case report and literature review.
    J Neuroimmunol. 2025;406:578670.
    PubMed         Abstract available
    
    
14. WON J, Kim J, Qiao F, Singh AK, et al
    Therapeutic potential of S-nitrosoglutathione reductase inhibitor in B cell-driven experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2025;406:578673.
    PubMed         Abstract available
    
    
15. ZIVOTIC I, Kolic I, Stefanovic M, Stefanovic NM, et al
    Association of TGFB1 and IFNB1 expression levels in peripheral blood mononuclear cells with multiple sclerosis with respect to proximal rs1800469 and rs2275888 eQTLs.
    J Neuroimmunol. 2025;406:578666.
    PubMed         Abstract available
    
    

    
    J Neurol

16. NAUTA IM, Loughlin KNM, Gravesteijn AS, van Wegen J, et al
    A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational study.
    J Neurol. 2025;272:476.
    PubMed         Abstract available
    
    

    
    J Pediatr

17. KHAYAT A, Vitola B
    Corrigendum to "Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease" [The Journal of Pediatrics volume 239 (2021) P155 - 160].
    J Pediatr. 2025 Jun 25:114677. doi: 10.1016/j.jpeds.2025.114677.
    PubMed        
    
    

    
    Kidney Int

18. HOU W, Yao Y, Dun D, Xia Y, et al
    Q fever endocarditis and glomerulonephritis.
    Kidney Int. 2025;108:156.
    PubMed        
    
    
19. CAZA TN, Arivett BA, Hassen SI, Al-Rabadi LF, et al
    Detection and Characterization of NELL1 Autoantibodies in NELL1 Positive Membranous Nephropathy.
    Kidney Int. 2025 Jun 18:S0085-2538(25)00481-8. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

20. SOKHI DS, Saylor D
    AFRICTRIMS: a step towards broadening multiple sclerosis conversations.
    Lancet Neurol. 2025;24:563-564.
    PubMed        
    
    
21. MOTTE J, Klimas R, Sgodzai M, Schucke C, et al
    CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies.
    Lancet Neurol. 2025;24:564-566.
    PubMed        
    
    

    
    Mult Scler

22. BALSHI A, Dempsey JP, Manning N, Leuenberger G, et al
    Malignant melanoma and multiple sclerosis therapies: A disproportionality analysis of the FDA adverse event reporting system.
    Mult Scler. 2025 Jun 25:13524585251342725. doi: 10.1177/13524585251342725.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

23. CAYUELA L, de Alboniga-Chindurza A, Gomez Enjuto S, Lapena-Motilva J, et al
    Multiple sclerosis mortality trends in Spain from 1981 to 2020.
    Neurologia (Engl Ed). 2025 Jun 23:S2173-5808(25)00053.
    PubMed         Abstract available
    
    

    
    PLoS One

24. DE DIOS PEREZ B, Kendrick D, das Nair R, Evangelou N, et al
    Optimising access to vocational rehabilitation through multiple sclerosis charities: Protocol for a feasibility randomised controlled trial.
    PLoS One. 2025;20:e0325570.
    PubMed         Abstract available
    
    
25. BOZZI S, Umarje S, Hawaldar K, Tyma J, et al
    Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.
    PLoS One. 2025;20:e0323843.
    PubMed         Abstract available
    
    
26. MOHAMED YM, Mancera J, Brandenberg A, Fischli S, et al
    Personalized machine learning models for noninvasive hypoglycemia detection in people with type 1 diabetes using a smartwatch: Insights into feature importance during waking and sleeping times.
    PLoS One. 2025;20:e0325956.
    PubMed         Abstract available
    
    
27. MARTIN-AVILA J, Rodriguez-Jimenez E, Valero-Moreno S, Gil-Gomez JA, et al
    Intervention through an intelligent technological platform for socio-emotional development and health promotion in adolescents with Type 1 Diabetes Mellitus (emoTICare): A study protocol for randomized controlled trial.
    PLoS One. 2025;20:e0325763.
    PubMed         Abstract available
    
    
28. CARAZO A, Paclikova M, Fadraersada J, Alva-Gallegos R, et al
    Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants.
    PLoS One. 2025;20:e0326580.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. JIANG Y, Liu Q, Stridh P, Kockum I, et al
    Multiomics integration prioritizes potential drug targets for multiple sclerosis.
    Proc Natl Acad Sci U S A. 2025;122:e2425537122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.